# Novel treatment options in rituximab-resistant membranous nephropathy patients

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/novel-treatment-options-in-rituximab-resistant-membranous-nephropathy-patients/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Elham Ahmadian,Seyed Mahdi Hosseiniyan Khatibi,Sepideh Zununi Vahed,Mohammadreza Ardalan |
| Citations | 14 |
| DOI | 10.1016/j.intimp.2022.108635 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4214618822 |
| PMID | 35240381 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Elham Ahmadian](https://scholariq.org/researchers/elham-ahmadian/)
- [Sepideh Zununi Vahed](https://scholariq.org/researchers/sepideh-zununi-vahed/)
- [Seyed Mahdi Hosseiniyan Khatibi](https://scholariq.org/researchers/seyed-mahdi-hosseiniyan-khatibi/)
- [Mohammadreza Ardalan](https://scholariq.org/researchers/mohammadreza-ardalan/)

## Paper journal

- [International Immunopharmacology](https://scholariq.org/journals/international-immunopharmacology/)

## Paper primary topic

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Paper topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.